CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA).

@article{Beaty2012CTII,
  title={CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA).},
  author={Karen A. Beaty and Joshua S. Hill and Safia Rafeeq and Michael James Overman and Tara L. Sagebiel and Aurelio Matamoros and Richard E. Royal and Paul F. Mansfield and Keith Francis Fournier},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2012},
  volume={30 4\_suppl},
  pages={434}
}
  • K. Beaty, Joshua S. Hill, +6 authors K. Fournier
  • Published 1 February 2012
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
434 Background: WDAA with peritoneal dissemination (PD) is a rare disease with a prognosis related to the ability to perform adequate cytoreductive surgery (CRS) with cytoreductive scores of 0 or 1 (CC0 or CC1) followed by HIPEC. Diagnostic imaging is an important aspect of post-operative surveillance. Often, surveillance imaging follows metastatic colon cancer guidelines with frequent CT scans performed during the first 5 years after resection (every 3 months for 2 years, then every 6 months…